日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rapid and durable recovery of immune effector cells in myelofibrosis patients treated with momelotinib

莫美替尼治疗骨髓纤维化患者的免疫效应细胞可快速且持久地恢复

Makker, Jasmine; Thaw, Kyaw Htin; Sheikh, Amna; Cadman-Davies, Llywelyn; Duminuco, Andrea; Torre, Elena; Panetta, Margherita; Stanley, Conor; De Lavallade, Hugues; Curto-Garcia, Natalia; Sriskandarajah, Priya; O'Sullivan, Jennifer; Radia, Deepti H; Woodley, Claire; Narciso, Benissa; Asirvatham, Susan; Psaila, Bethan; Kordasti, Shahram; Harrison, Claire; Harrington, Patrick

Tumor-Infiltrating Clonal Hematopoiesis

肿瘤浸润性克隆性造血

Pich, Oriol; Bernard, Elsa; Zagorulya, Maria; Rowan, Andrew; Pospori, Constandina; Slama, Ramy; Huerga Encabo, Hector; O'Sullivan, Jennifer; Papazoglou, Despoina; Anastasiou, Panayiotis; Iliakis, Chrysante S; Clark, Sally-Ann; Dijkstra, Krijn K; Barbè, Vittorio; Bailey, Chris; Stonestrom, Aaron J; Enfield, Katey S S; Green, Mary; Brierley, Charlotte K; Magness, Alastair; Pearce, David R; Hynds, Robert E; Zaidi, Rija; Rane, Jayant K; Álvarez-Prado, Ángel F; Thol, Kerstin; Scott, Rachel; Bola, Supreet Kaur; Hoxha, Elena; Harris, Steve K; Peggs, Karl S; Quezada, Sergio A; Hackshaw, Allan; Zaccaria, Simone; Joyce, Johanna A; Malanchi, Ilaria; Berger, Michael F; Jamal-Hanjani, Mariam; Wack, Andreas; Downward, Julian; Grey, William; Lo Celso, Cristina; Grönroos, Eva; Rudin, Charles M; Mead, Adam J; Bonnet, Dominique; Papaemmanuil, Elli; Swanton, Charles

QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms

QRISK3评分可预测骨髓增生性肿瘤患者的血栓风险。

Duminuco, Andrea; Vaghela, Raj; Virdee, Sukhraj; Woodley, Claire; Asirvatham, Susan; Curto-Garcia, Natalia; Sriskandarajah, Priya; O'Sullivan, Jennifer; de Lavallade, Hugues; Radia, Deepti; Kordasti, Shahram; Palumbo, Giuseppe A; Harrison, Claire; Harrington, Patrick

Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety

使用 Janus 激酶抑制剂治疗骨髓增生性肿瘤:心血管安全性荟萃分析

Dunn, Roberta; Long, Edouard; Gagnon, Laura Li; Harrison, Claire; Yang, Yunfan; O'Sullivan, Jennifer

Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms

开发用于评估骨髓增生性肿瘤患者心血管风险的自然语言处理流程

Duminuco, Andrea; Au Yeung, Joshua; Vaghela, Raj; Virdee, Sukhraj; Woodley, Claire; Asirvatham, Susan; Curto-Garcia, Natalia; Sriskandarajah, Priya; O'Sullivan, Jennifer; de Lavallade, Hugues; Radia, Deepti; Kordasti, Shahram; Palumbo, Giuseppe; Harrison, Claire; Harrington, Patrick

A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.

促炎干细胞微环境通过可靶向的半乳糖凝集素-1轴驱动骨髓纤维化

Li Rong, Colombo Michela, Wang Guanlin, Rodriguez-Romera Antonio, Benlabiod Camelia, Jooss Natalie J, O'Sullivan Jennifer, Brierley Charlotte K, Clark Sally-Ann, Pérez Sáez Juan M, Fernández Pedro Aragón, Schoof Erwin M, Porse Bo, Meng Yiran, Khan Abdullah O, Wen Sean, Dong Pengwei, Zhou Wenjiang, Sousos Nikolaos, Murphy Lauren, Clarke Matthew, Olijnik Aude-Anais, Wong Zoë C, Karali Christina Simoglou, Sirinukunwattana Korsuk, Ryou Hosuk, Norfo Ruggiero, Cheng Qian, Carrelha Joana, Ren Zemin, Thongjuea Supat, Rathinam Vijay A, Krishnan Anandi, Royston Daniel, Rabinovich Gabriel A, Mead Adam J, Psaila Bethan

A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial

一项针对既往接受过鲁索替尼治疗或不适合接受鲁索替尼治疗的骨髓纤维化患者的随机、双盲研究:一项 II 期试验的第二阶段,评估了辛喷曲辛α的疗效。

Verstovsek, Srdan; Talpaz, Moshe; Wadleigh, Martha; Isidori, Alessandro; Te Boekhorst, Peter; Savona, Michael R; Bose, Prithviraj; Pozdnyakova, Olga; Mesa, Ruben; El-Galaly, Tarec C; O'Sullivan, Jennifer; Gamel, Katia; Higgins, Brian; Katakam, Sudhakar; Todorov, Boyan; Trunzer, Kerstin; Harrison, Claire N

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

鲁索替尼与现有最佳疗法治疗对羟基脲不耐受或耐药的真性红细胞增多症的随机试验

Harrison, Claire N; Nangalia, Jyoti; Boucher, Rebecca; Jackson, Aimee; Yap, Christina; O'Sullivan, Jennifer; Fox, Sonia; Ailts, Isaak; Dueck, Amylou C; Geyer, Holly L; Mesa, Ruben A; Dunn, William G; Nadezhdin, Eugene; Curto-Garcia, Natalia; Green, Anna; Wilkins, Bridget; Coppell, Jason; Laurie, John; Garg, Mamta; Ewing, Joanne; Knapper, Steven; Crowe, Josephine; Chen, Frederick; Koutsavlis, Ioannis; Godfrey, Anna; Arami, Siamak; Drummond, Mark; Byrne, Jennifer; Clark, Fiona; Mead-Harvey, Carolyn; Baxter, Elizabeth Joanna; McMullin, Mary Frances; Mead, Adam J

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

在同情用药的基础上,对晚期骨髓纤维化患者进行帕克替尼的长期治疗

Harrison, Claire; Yacoub, Abdulraheem; Scott, Bart; Mead, Adam; Gerds, Aaron T; Kiladjian, Jean-Jacques; Mesa, Ruben; Egyed, Miklos; Scheid, Christof; Gutierrez, Valentin Garcia; O'Sullivan, Jennifer; Buckley, Sarah; Kanellopoulos, Kris; Mascarenhas, John

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)

在接受聚乙二醇干扰素α-2a (Pegasys) 治疗后,原发性血小板增多症和真性红细胞增多症患者使用罗培干扰素α-2b (Besremi) 的真实世界经验

Okikiolu, Jumoke; Woodley, Claire; Cadman-Davies, Llywelyn; O'Sullivan, Jennifer; Radia, Deepti; Garcia, Natalia Curto; Harrington, Patrick; Kordasti, Shahram; Asirvatham, Susan; Sriskandarajah, Priya; Saunders, Jamie; Saha, Chandan; Sanchez, Irene; deLavallade, Hugues; McLornan, Donal P; Harrison, Claire N